Related Experiment Videos
Clinical activity assessment in inflammatory bowel disease
1Department of Medicine, University of Colorado Medical School, Denver 80262.
Digestive Diseases and Sciences
|December 1, 1987
Summary
Standardized clinical observation methods are crucial for inflammatory bowel disease (IBD) trials. While a universal disease activity measure remains elusive, clinician consensus on basic observations can enable reliable therapeutic outcome comparisons.
Area of Science:
- Gastroenterology
- Clinical Trials Methodology
- Patient Monitoring
Background:
- Standardized clinical observation methods are essential for inflammatory bowel disease (IBD) research.
- Previous attempts to create universal assessment tools since the 1950s have not achieved widespread acceptance.
- The need for consistent data collection in IBD clinical trials is ongoing.
Purpose of the Study:
- To highlight the necessity of standardized clinical observation methods in inflammatory bowel disease (IBD).
- To discuss the challenges in developing a universally accepted disease activity instrument for Crohn's disease and ulcerative colitis.
- To advocate for clinician agreement on basic observational practices for improved research.
Main Methods:
- Review of historical and current efforts in standardizing IBD clinical assessments.
- Discussion of the requirements for effective clinical trial conduct and practice application.
- Exploration of the potential for consensus-building among clinicians.
Main Results:
- A single, universally accepted clinical instrument for measuring IBD disease activity is unlikely to be developed.
- Agreement on a basic set of standardized observations and recording methods is achievable.
- Such agreement can facilitate accurate comparisons of therapeutic outcomes across different studies and settings.
Conclusions:
- Standardized methods for recording clinical observations in inflammatory bowel disease are critical.
- Achieving consensus on fundamental observational practices among clinicians is a viable goal.
- This consensus will enable more reliable comparisons of treatment efficacy in IBD research and practice.